European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

Unconventional NMDAR signaling theory for Fragile X Syndrome

Descrizione del progetto

Indagine sulla plasticità sinaptica nella sindrome dell’X fragile

I neuroni modificano continuamente le loro connessioni con i neuroni vicini attraverso un processo conosciuto come plasticità sinaptica, che altera la forza e la struttura sinaptica. Il processo è altamente regolato dai recettori NMDA e consente ai neuroni di elaborare le nuove informazioni. Gli scienziati del progetto METAFRAX, finanziato dall’UE, esamineranno l’ipotesi secondo cui i recettori NMDA sono disfunzionali nella sindrome dell’X fragile (FXS, Fragile X Syndrome), la causa più comune di disabilità intellettive ereditate. In un modello murino dell’FXS, essi studieranno i meccanismi responsabili dell’alterazione della plasticità sinaptica, contribuendo significativamente alla comprensione della base molecolare della plasticità sinaptica. Il progetto fungerà da base per la scoperta futura dei bersagli terapeutici per l’FXS e altre condizioni che presentano disturbi cognitivi.

Obiettivo

Fragile X syndrome (FXS) is the most common cause of inherited intellectual disability (ID), and the leading known genetic cause of autism. This dominant phenotype represents a huge hindrance for clinicians in the treatment of FXS because the underlying neuronal deficits remain unknown. Individual neurons store information as we learn and acquire new information by modifying their connections with nearby neurons, a process called synaptic plasticity. This refers to activity-dependent long-term changes in synaptic strength but also synaptic structure, and is highly regulated by NMDA receptors (NMDAR). It has recently been proposed that NMDARs can signal in an unconventional manner. Our goal is to understand how unconventional NMDRs drive synaptic plasticity, and how this is dysregulated in the mouse model of FXS. For this, we will record electrical activity of the neurons and image synaptic structures during different forms of synaptic plasticity, and characterise metabotropic NMDAR signaling by functional genomic approaches.
In summary, we will use a multi-disciplinary approach to unravel the mechanisms responsible for synaptic plasticity alteration in the mouse model for FXS and further our understanding of the neuronal processes underlying cognitive phenotypes of FXS. The outcomes of these experiments will not only offer hope to patients with FXS but will also further our understanding of the molecular basis of synaptic plasticity. If successful, this could serve as the basis for future molecular targets to promote cognitive recovery from ID, autism spectrum disorders and other diseases.
The project is an excellent opportunity for the researcher to further develop her knowledge and to position her in unique multidisciplinary environment that will foster her career progression towards independence. The researcher’s experience acquired at MIT and during the outgoing phase at McGill will be extremely valuable for the host institution and the European research area.

Coordinatore

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Contribution nette de l'UE
€ 244 385,28
Indirizzo
RUE MICHEL ANGE 3
75794 Paris
Francia

Mostra sulla mappa

Regione
Ile-de-France Ile-de-France Paris
Tipo di attività
Research Organisations
Collegamenti
Costo totale
€ 244 385,28

Partner (1)